HOX cluster intergenic non-coding RNAs in myeloid differentiation and function

HOX簇基因间非编码RNA在骨髓分化和功能中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Neutrophils and differentiating myeloid cells are unusually rich in the expression of non-coding RNA (ncRNA) transcripts, particularly intergenic transcripts from the homeobox-containing (HOX) gene clusters. In contrast to the well-studied functions of HOX genes in embryonic pattern formation, their roles in hematopoiesis are less well understood. We have identified a HOX region ncRNA, HOTAIRM1, that is expressed specifically in myeloid cells and regulates the expression of genes in the proximal HOXA cluster. We propose a detailed study of intergenic transcripts in the HOXA cluster, with the objectives of determining the functions of HOTAIRM1 and other HOXA ncRNAs in the regulation of HOX gene expression, myeloid differentiation, and mature neutrophil function. Central hypothesis: HOTAIRM1 and other non-coding intergenic transcripts in the HOXA gene cluster regulate the expression of developmentally important HOX genes, thereby modulating myeloid differentiation and function. Specifically, we will: 1. Investigate the function of HOTAIRM1 in the regulation of HOX gene expression. Hypothesis: HOTAIRM1 regulates the pattern of HOX gene expression during myeloid differentiation. Each subaim tests a hypothesis regarding a specific regulatory pattern: A. Regulation of individual HOX genes within the HOXA cluster, by either cis or trans actions; B. Differential regulation of sets of 5' versus 3' HOXA cluster genes; C. Preferential repression or activation of HOXB and non-clustered homeobox genes 2. Determine the mechanisms of HOTAIRM1 regulation of HOX gene expression. Each of the following subaims tests a specific, non-exclusive hypothesis that the specific mechanism under examination contributes to the regulatory functions of HOTAIRM1: A. Subcellular localization and molecular neighbors of HOTAIRM1; B. Molecules associated with HOTAIRM1; C. Regulation of transcriptional activity; D. Regulation of chromatin structure; E. Post-transcriptional regulation of mRNA stability and translation. 3. Test the effects of HOXA cluster intergenic ncRNAs on myeloid development and function. A. Effects of HOTAIRM1 knockdown or overexpression on myeloid gene expression, differentiation and function. Hypothesis: HOTAIRM1 regulates myeloid lineage commitment, differentiation, and function through control of myeloid genes and downstream effectors. B. Effects of knockdown or overexpression of additional HOXA intergenic ncRNAs. Hypothesis: Multiple HOX region intergenic transcripts cooperatively regulate myeloid gene expression and function. Characterization of other HOXA intergenic ncRNAs expressed in myeloid cells; knockdown and overexpression of additional HOXA intergenic transcripts The proposed studies will increase our fundamental understanding of myeloid gene regulation, differentiation, and function. The results could reveal potential targets for intervention in disorders of myeloid maturation, such as myelodysplasia and leukemia, as well as neutrophil-mediated inflammation disorders. PUBLIC HEALTH RELEVANCE: The proposed studies should determine the roles of a novel non-coding RNA transcripts in myeloid differentiation and mature neutrophil function. The results will increase our fundamental understanding of these processes and could reveal potential targets for intervention in disorders of myeloid maturation, such as myelodysplasia and leukemia, and in neutrophil-mediated inflammatory disorders, such as arthritis, inflammatory bowel disease, and post-ischemic tissue injury.
描述(由申请人提供):中性粒细胞和分化的髓细胞异常丰富非编码RNA (ncRNA)转录物的表达,特别是来自同源盒(HOX)基因簇的基因间转录物。与HOX基因在胚胎模式形成中的功能得到充分研究相比,它们在造血中的作用却鲜为人知。我们已经确定了一个HOX区域的ncRNA HOTAIRM1,它在髓系细胞中特异性表达,并调节近端HOXA簇基因的表达。我们提议对HOXA簇中的基因间转录物进行详细的研究,目的是确定HOTAIRM1和其他HOXA ncRNAs在调节HOX基因表达、髓细胞分化和成熟中性粒细胞功能中的功能。中心假设:HOTAIRM1和HOXA基因簇中的其他非编码基因间转录物调节发育中重要HOX基因的表达,从而调节髓细胞分化和功能。具体来说,我们将:1。探讨HOTAIRM1在调控HOX基因表达中的作用。假设:HOTAIRM1调控髓细胞分化过程中HOX基因的表达模式。每个子目标测试一个关于特定调控模式的假设:a .通过顺式或反式对HOXA集群内单个HOX基因的调控;B. 5‘和3’ HOXA簇基因组的差异调控;3 . HOXB和非聚类同源盒基因的优先抑制或激活确定HOTAIRM1调控HOX基因表达的机制。以下每个子目标都验证了一个特定的、非排他的假设,即所研究的特定机制有助于HOTAIRM1的调节功能:a . HOTAIRM1的亚细胞定位和分子邻居;B. HOTAIRM1相关分子;C.转录活性调控;D.染色质结构的调控;E. mRNA稳定性和翻译的转录后调控。3. 检测HOXA簇基因间ncrna对髓细胞发育和功能的影响。A. HOTAIRM1敲低或过表达对髓系基因表达、分化和功能的影响。假设:HOTAIRM1通过控制髓系基因和下游效应物调节髓系谱系的承诺、分化和功能。B.敲低或过表达额外HOXA基因间ncrna的影响。假设:多个HOX区基因间转录物协同调节髓系基因的表达和功能。髓细胞中表达的其他HOXA基因间ncrna的特性提出的研究将增加我们对髓系基因调控、分化和功能的基本理解。该结果可能揭示骨髓成熟障碍的潜在干预靶点,如骨髓发育不良和白血病,以及中性粒细胞介导的炎症障碍。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER E NEWBURGER其他文献

PETER E NEWBURGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER E NEWBURGER', 18)}}的其他基金

Severe Chronic Neutropenia International Registry
严重慢性中性粒细胞减少症国际登记处
  • 批准号:
    10410150
  • 财政年份:
    2022
  • 资助金额:
    $ 6.2万
  • 项目类别:
Novel Approach to Oral Gene Therapy for Chronic Granulomatous Disease
慢性肉芽肿性疾病口服基因治疗的新方法
  • 批准号:
    7740349
  • 财政年份:
    2009
  • 资助金额:
    $ 6.2万
  • 项目类别:
Novel Approach to Oral Gene Therapy for Chronic Granulomatous Disease
慢性肉芽肿性疾病口服基因治疗的新方法
  • 批准号:
    7806438
  • 财政年份:
    2009
  • 资助金额:
    $ 6.2万
  • 项目类别:
Gene expression in mature neutrophils
成熟中性粒细胞中的基因表达
  • 批准号:
    7982456
  • 财政年份:
    2009
  • 资助金额:
    $ 6.2万
  • 项目类别:
TRANSCRIPTIONAL REGULATION IN STEM CELLS
干细胞的转录调控
  • 批准号:
    6358987
  • 财政年份:
    2000
  • 资助金额:
    $ 6.2万
  • 项目类别:
REG OF THE NADPH OXIDASE BY ANTI-INFLAMMATORY AGENTS
抗炎药对 NADPH 氧化酶的调节
  • 批准号:
    2631255
  • 财政年份:
    1999
  • 资助金额:
    $ 6.2万
  • 项目类别:
GENE EXPRESSION IN MATURE NEUTROPHILS
成熟中性粒细胞的基因表达
  • 批准号:
    2843565
  • 财政年份:
    1999
  • 资助金额:
    $ 6.2万
  • 项目类别:
Gene expression in mature neutrophils
成熟中性粒细胞中的基因表达
  • 批准号:
    7070623
  • 财政年份:
    1999
  • 资助金额:
    $ 6.2万
  • 项目类别:
REG OF THE NADPH OXIDASE BY ANTI-INFLAMMATORY AGENTS
抗炎药对 NADPH 氧化酶的调节
  • 批准号:
    6394921
  • 财政年份:
    1999
  • 资助金额:
    $ 6.2万
  • 项目类别:
GENE EXPRESSION IN MATURE NEUTROPHILS
成熟中性粒细胞的基因表达
  • 批准号:
    6381210
  • 财政年份:
    1999
  • 资助金额:
    $ 6.2万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
  • 批准号:
    MR/Y009681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
  • 批准号:
    MR/Y022947/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
  • 批准号:
    10068495
  • 财政年份:
    2024
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
  • 批准号:
    24K19850
  • 财政年份:
    2024
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
  • 批准号:
    491810
  • 财政年份:
    2023
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
  • 批准号:
    489316
  • 财政年份:
    2023
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Operating Grants
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
  • 批准号:
    23K14987
  • 财政年份:
    2023
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
  • 批准号:
    EP/Y027760/1
  • 财政年份:
    2023
  • 资助金额:
    $ 6.2万
  • 项目类别:
    Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
  • 批准号:
    10733789
  • 财政年份:
    2023
  • 资助金额:
    $ 6.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了